Not yet taking people in Ausztria1. fázis
First study evaluating the safety and dosage of YG-01 in patients with a malignant brain tumor
Key facts
- Where
- Vienna, AusztriaSee the site
- Phase
- 1. fázis
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- How old are you?
Where in Ausztria
- Medical University of ViennaVienna, AusztriaToborzás még nem indult
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Ygion Biomedical GmbH
- Trial code
- EU 2025-524299-44-00
- Record updated
- 2026. június 29.